Stock Screener App

Frei -

Installieren

2.50

11.11% 0.25

Vistagen Therapeutics Inc (VTGN)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose Aktiensplit

Finanzdaten der Vistagen Therapeutics Inc-Aktie (VTGN)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	48.15% 0.4114	0.2777	0.0972	0.176	0.18
Operating Expenses	17.53% 8.2954	7.0579	7.1754	12.41	9.946
Benefits Costs and Expenses	1.52% 6.7612	6.8654	6.9978	12.40	9.941
Costs And Expenses	1.52% 6.7612	6.8654	6.9978	12.40	9.941
Provision For Loan, Lease, And Other Losses	-	-	-	-	-
Operating Income/Loss	16.28% -7.884	-6.7802	-6.9978	-12.24	-9.766
Net Interest Income/Expense	696.99% 1.5342	0.1925	0.0972	0.013	0.005
Interest Income/Expense After Provision For Losses	696.99% 1.5342	0.1925	0.0972	0.013	0.005
Income/Loss From Continuing Operations Before Tax	3.61% -6.3498	-6.5877	-6.9006	-12.23	-9.761
Income Tax Expense/Benefit	-	-	0.0025	0.001	-
Income/Loss From Continuing Operations After Tax	3.61% -6.3498	-6.5877	-6.9031	-12.23	-9.761
Net Income/Loss	3.61% -6.3498	-6.5877	-6.9031	-12.23	-9.761
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	192.64% 29.39	10.04	7.377	7.1638	6.8946
Basic Earnings Per Share	66.67% -0.22	-0.66	-0.94	-1.71	-1.42
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-

SMMT

$17.87

2.88%

INCY

$68.84

2.65%

MRNA

$39.39

0.43%

UTHR

$359.58

0.16%

BGNE

$176.50

1.02%

BNTX

$113.08

1.56%

In Yahoo öffnen | In Google öffnen | In Finviz öffnen | In MarketWatch öffnen | Öffnen Sie in EDGAR | Offen in Reuters